S&P 500   4,502.27 (-1.63%)
DOW   34,327.75 (-0.90%)
QQQ   380.08 (-2.52%)
AAPL   160.24 (-2.15%)
MSFT   320.30 (-2.79%)
FB   303.32 (-2.28%)
GOOGL   2,818.47 (-1.43%)
AMZN   3,355.20 (-2.39%)
TSLA   1,011.46 (-6.74%)
NVDA   303.11 (-5.65%)
BABA   112.24 (-8.00%)
NIO   31.81 (-12.13%)
CGC   9.96 (-3.86%)
AMD   141.73 (-5.94%)
GE   91.93 (-3.47%)
MU   81.04 (-2.22%)
T   23.37 (+1.39%)
F   19.02 (-4.28%)
DIS   144.69 (-1.71%)
PFE   54.22 (+2.22%)
AMC   25.57 (-15.55%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
S&P 500   4,502.27 (-1.63%)
DOW   34,327.75 (-0.90%)
QQQ   380.08 (-2.52%)
AAPL   160.24 (-2.15%)
MSFT   320.30 (-2.79%)
FB   303.32 (-2.28%)
GOOGL   2,818.47 (-1.43%)
AMZN   3,355.20 (-2.39%)
TSLA   1,011.46 (-6.74%)
NVDA   303.11 (-5.65%)
BABA   112.24 (-8.00%)
NIO   31.81 (-12.13%)
CGC   9.96 (-3.86%)
AMD   141.73 (-5.94%)
GE   91.93 (-3.47%)
MU   81.04 (-2.22%)
T   23.37 (+1.39%)
F   19.02 (-4.28%)
DIS   144.69 (-1.71%)
PFE   54.22 (+2.22%)
AMC   25.57 (-15.55%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
S&P 500   4,502.27 (-1.63%)
DOW   34,327.75 (-0.90%)
QQQ   380.08 (-2.52%)
AAPL   160.24 (-2.15%)
MSFT   320.30 (-2.79%)
FB   303.32 (-2.28%)
GOOGL   2,818.47 (-1.43%)
AMZN   3,355.20 (-2.39%)
TSLA   1,011.46 (-6.74%)
NVDA   303.11 (-5.65%)
BABA   112.24 (-8.00%)
NIO   31.81 (-12.13%)
CGC   9.96 (-3.86%)
AMD   141.73 (-5.94%)
GE   91.93 (-3.47%)
MU   81.04 (-2.22%)
T   23.37 (+1.39%)
F   19.02 (-4.28%)
DIS   144.69 (-1.71%)
PFE   54.22 (+2.22%)
AMC   25.57 (-15.55%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
S&P 500   4,502.27 (-1.63%)
DOW   34,327.75 (-0.90%)
QQQ   380.08 (-2.52%)
AAPL   160.24 (-2.15%)
MSFT   320.30 (-2.79%)
FB   303.32 (-2.28%)
GOOGL   2,818.47 (-1.43%)
AMZN   3,355.20 (-2.39%)
TSLA   1,011.46 (-6.74%)
NVDA   303.11 (-5.65%)
BABA   112.24 (-8.00%)
NIO   31.81 (-12.13%)
CGC   9.96 (-3.86%)
AMD   141.73 (-5.94%)
GE   91.93 (-3.47%)
MU   81.04 (-2.22%)
T   23.37 (+1.39%)
F   19.02 (-4.28%)
DIS   144.69 (-1.71%)
PFE   54.22 (+2.22%)
AMC   25.57 (-15.55%)
ACB   5.76 (-6.19%)
BA   196.06 (-3.12%)
NASDAQ:GBIO

Generation Bio Insider Trades

$14.86
-1.02 (-6.42%)
(As of 12/3/2021 02:58 PM ET)
Add
Compare
Today's Range
$14.81
$15.94
50-Day Range
$15.41
$27.18
52-Week Range
$15.01
$53.50
Volume
6,354 shs
Average Volume
416,372 shs
Market Capitalization
$845.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
3.86

Generation Bio (NASDAQ:GBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
23.90%

Number Of
Insiders Buying
(Last 12 Months)
1

Amount Of
Insider Buying
(Last 12 Months)
$99.98 K

Number Of
Insiders Selling
(Last 12 Months)
5

Amount Of
Insider Selling
(Last 12 Months)
$22.94 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get GBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Generation Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Generation Bio (NASDAQ GBIO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/29/2021Jason P RhodesDirectorSell16,586$24.59$407,849.74  
9/29/2021Venture Associates X L AtlasMajor ShareholderSell16,556$24.59$407,112.04  
9/27/2021Jason P RhodesDirectorSell51,389$25.70$1,320,697.30  
9/27/2021Venture Associates X L AtlasMajor ShareholderSell51,294$25.70$1,318,255.80  
9/24/2021Jason P RhodesDirectorSell28,916$25.84$747,189.44  
9/24/2021Venture Associates X L AtlasMajor ShareholderSell28,862$25.84$745,794.08  
9/22/2021Jason P RhodesDirectorSell30,617$25.89$792,674.13  
9/22/2021Venture Associates X L AtlasMajor ShareholderSell30,560$25.89$791,198.40  
8/23/2021Matthew StantonInsiderSell1,500$25.04$37,560.00  
8/10/2021Matthew StantonInsiderSell1,500$22.63$33,945.00  
7/12/2021Matthew StantonInsiderSell3,000$25.03$75,090.00  
7/8/2021Douglas KerrInsiderSell3,518$25.20$88,653.60330,076  
6/23/2021Jason P RhodesDirectorSell62,609$25.36$1,587,764.24  
6/23/2021Venture Associates X L AtlasMajor ShareholderSell62,493$25.36$1,584,822.48  
6/21/2021Jason P RhodesDirectorSell63,892$24.84$1,587,077.28  
6/21/2021Venture Associates X L AtlasMajor ShareholderSell63,774$24.84$1,584,146.16  
6/15/2021Matthew StantonInsiderSell1,500$28.08$42,120.00199,654  
6/10/2021Matthew StantonInsiderSell6,000$27.23$163,380.00204,154  
5/27/2021Matthew StantonInsiderSell1,500$34.05$51,075.00199,654  
5/11/2021Matthew StantonInsiderSell400$31.05$12,420.00206,754  
4/23/2021Geoff McdonoughCEOSell10,000$35.10$351,000.001,184,080  
4/22/2021Matthew StantonInsiderSell3,000$32.55$97,650.00
4/16/2021Matthew StantonInsiderSell1,500$28.03$42,045.00199,654  
4/14/2021Jason P RhodesDirectorSell23,413$26.61$623,019.93  
4/13/2021Venture Associates X L AtlasMajor ShareholderSell43,145$25.16$1,085,528.20  
4/12/2021Jason P RhodesDirectorSell74,124$26.15$1,938,342.60  
4/12/2021Matthew StantonInsiderSell6,000$26.24$157,440.00204,154  
4/9/2021Venture Associates X L AtlasMajor ShareholderSell43,681$27.61$1,206,032.41  
4/8/2021Jason P RhodesDirectorSell43,550$28.50$1,241,175.00  
4/7/2021Venture Associates X L AtlasMajor ShareholderSell39,864$28.51$1,136,522.64  
4/5/2021Douglas KerrInsiderSell14,072$30.09$423,426.48340,630  
3/10/2021Matthew StantonInsiderSell10,500$34.97$367,185.00208,654  
1/14/2021Matthew StantonInsiderSell5,630$32.54$183,200.20203,784  
1/11/2021Donald William NicholsonDirectorBuy4,081$24.50$99,984.50103,157  
1/11/2021Douglas KerrInsiderSell11,267$27.58$310,743.86337,825  
12/10/2020Matthew StantonInsiderSell10,540$37.62$396,514.80208,694  
6/16/2020James E FlynnInsiderBuy225,000$19.00$4,275,000.00
(Data available from 1/1/2013 forward)












Generation Bio (NASDAQ:GBIO) Insider Trade Frequently Asked Questions

Who is on Generation Bio's Insider Roster?

The list of insiders at Generation Bio includes Donald William Nicholson, Douglas Kerr, Geoff Mcdonough, James E Flynn, Jason P Rhodes, Matthew Stanton, and Venture Associates X L Atlas.Learn more on GBIO's insiders

What percentage of Generation Bio stock is owned by insiders?

23.90% of Generation Bio stock is owned by insiders. Learn more on GBIO's insider holdings

Which Generation Bio insiders have been buying company stock?

The following insiders have purchased Generation Bio stock in the last 24 months: Donald William Nicholson ($99,984.50), and James E Flynn ($4,275,000.00).

How much insider buying is happening at Generation Bio?

Insiders have purchased a total of 229,081 Generation Bio shares in the last 24 months for a total of $4,374,984.50 bought.

Which Generation Bio insiders have been selling company stock?

The following insiders have sold Generation Bio stock in the last 24 months: Douglas Kerr ($822,823.94), Geoff Mcdonough ($351,000.00), Jason P Rhodes ($10,245,789.66), Matthew Stanton ($1,659,625.00), and Venture Associates X L Atlas ($9,859,412.21).

How much insider selling is happening at Generation Bio?

Insiders have sold a total of 866,752 Generation Bio shares in the last 24 months for a total of $22,938,650.81 sold.

This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.